EFFECTS OF ATRASENTAN ON MARKERS OF LIVER FUNCTION IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Back
Abstract Number
WCN23-1030
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
EFFECTS OF ATRASENTAN ON MARKERS OF LIVER FUNCTION IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Co-authors
Lambers Heerspink, H.(1)*;Liew, A.(2);Tang, S.C.W.(3);Barratt, J.(4);Kohan, D.(5);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)University Medical Center Groningen, Clinical Pharmacy And Pharmacology, Groningen Groningen, Netherlands;(2)Mount Elizabeth Novena Hospital, Renal Medicine, Singapore, Singapore;(3)The University Of Hong Kong, Department Of Medicine, Hong Kong, China;(4)University Hospitals Of Leicester, Department Of Cardiovascular Sciences, Leicester, United Kingdom;(5)University Of Utah Health, Division Of Nephrology, Salt Lake City, United States;
E-Poster
https://storage.unitedwebnetwork.com/files/1/29827e1e8f75857777fc39548c0b6175.pdf
Audio File
if any